Cargando...
Haploidentical Donor Transplantation Using a Novel Clofarabine-Containing Conditioning Regimen for Very High-Risk Hematologic Malignant Neoplasms
Recurrent/refractory hematologic malignancies have a poor prognosis, and there is a need for novel treatment regimens that can be tolerated by this heavily pretreated patient group. Clofarabine has antileukemic activity with an acceptable toxicity profile. In a phase I clinical trial (NCT00824135),...
Gardado en:
| Publicado en: | J Pediatr Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6197927/ https://ncbi.nlm.nih.gov/pubmed/29750747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000001222 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|